IMMUNOGENES
ImmunoGenes is a biotech company with a platform technology that improves the immune response using genetically-modified mice and rabbits that overexpress the neonatal Fc receptor (FcRn). Their IMG-AbS:tm: patented technology results in a greater number and greater diversity of B cell clones than is typical and a strong immune response against weakly immunogenic targets. This, in turn, generates high-quality monoclonal antibody candidates with high affinity and diversity that pharmaceutical and ... biotech companies can use in their development of unique therapeutics and diagnostics. ImmunoGenes discovers and develops its antibody drugs in collaboration with pharmaceutical, institutional and academic partners. They are employing their proprietary technologies, including IMG-Abs:tm: to discover, develop and commercialise monoclonal antibodies to difficult and novel targets.
IMMUNOGENES
Social Links:
Industry:
Biotechnology Medical
Founded:
2007-01-01
Address:
Budakeszi, Pest, Hungary
Country:
Hungary
Website Url:
http://www.immunogenes.com
Total Employee:
1+
Status:
Active
Contact:
+36-30-757-7870
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Font Awesome Apache
Similar Organizations
Marinomed
Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.
Current Advisors List
Investors List
Texas HALO Fund
Texas HALO Fund investment in Series A - ImmunoGenes
Official Site Inspections
http://www.immunogenes.com
- Host name: s7.mcvps.hu
- IP address: 92.43.203.149
- Location: Hungary
- Latitude: 47.4919
- Longitude: 19.05
- Timezone: Europe/Budapest
More informations about "ImmunoGenes"
Immunogenes - Home
ImmunoGenes ImmunoGenes is a biotech company with a cutting-edge technology in antibody and genetically modified animal technologies. More about usSee details»
ImmunoGenes - Crunchbase Company Profile & Funding
ImmunoGenes is a biopharmaceutical company developing a platform which improves the immune system's response.See details»
Immunogenes - About
About us ImmunoGenes was established in 2007 by Prof. Dr. Imre Kacskovics, with a serendipitous discovery. The technology since then was patented and used several times.See details»
ImmunoGenes - LinkedIn
ImmunoGenes owns a patented technology, which provides enhanced immune response and thus greater possibility to produce the right antibody, than the usually used techniques.See details»
ImmunoGenes 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for ImmunoGenes. Use the PitchBook Platform to explore the full profile.See details»
ImmunoGenes Company Profile | Management and Employees List …
Find contact information for ImmunoGenes. Learn about their Research & Development, Business Services market share, competitors, and ImmunoGenes's email format.See details»
ImmunoGenes Company Profile - Office Locations, Competitors
See insights on ImmunoGenes including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
ImmunoGenes AG: Drug pipelines, Patents, Clinical trials - Synapse
Aug 7, 2023 Explore ImmunoGenes AG with its drug pipeline, therapeutic area, technology platform, 3 literature.See details»
ImmunoGenes - Clinical Trials Arena
ImmunoGenes is a biotechnology company focusing on the development of new therapeutic medications and strategies. The company offers custom antibody services (CAS) and custom …See details»
Immunogenes - Resources
Cell-specific STORM superresolution imaging reveals nanoscale organization of cannabinoid signaling Barna Dudok, László Barna, Marco Ledri, Szilárd I. Szabó, Eszter Szabadits, Balázs …See details»
ImmunoGenes - Funding, Financials, Valuation & Investors
ImmunoGenes is a biopharmaceutical company developing a platform which improves the immune system's response.See details»
ImmunoGenes - Contacts, Employees, Board Members, Advisors
ImmunoGenes is a biopharmaceutical company developing a platform which improves the immune system's response.See details»
ImmunoGenes Locations - Contract Research Map
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations …See details»
ImmunoGenes: Drug pipelines, Patents, Clinical trials - Synapse
Explore ImmunoGenes with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
ImmunoGen is now part of AbbVie | AbbVie
Our scientists and oncologists strive to give patients improved treatment outcomes and a life beyond cancer by developing therapies that elevate the standards of care.See details»
Immunogenes - Success stories
Cell-specific STORM superresolution imaging reveals nanoscale organization of cannabinoid signalingSee details»
ImmunoGen - Crunchbase Company Profile & Funding
ImmunoGen engages in the research and development of antibody-based anticancer therapeutics using its targeted antibody payload technology.See details»
ImmunoGenesis
We are rapidly translating the most cutting-edge discoveries from academic tumor immunology into drugs optimized for treating the majority of patients who have "cold" cancers refractory to …See details»
Statement on the antigen composition of COVID-19 vaccines
2 days ago The TAG-CO-VAC reconvened on 6-7 May 2025 to review the genetic and antigenic evolution of SARS-CoV-2; immune responses to SARS-CoV-2 infection and/or COVID-19 …See details»
Immunogenes - Technology
Technology Catalogue models Anti CB1 (mouse) Monoclonal Antibody Anti-Insulin (mouse) Monoclonal Antibody Anti CB1 (rabbit) Polyclonal Antibody Anti NOX5 (mouse) Monoclonal …See details»